Project: Quality Control and Purification for New Biological Drugs (BIO-QC)

The BIO-QC project will develop new materials and processes for quality control of pharmaceuticals derived from so-called biomolecules.

Project information

Project manager at Linnaeus University
Ian Nicholls
Other project members
Linnaeus University: Jesper Wiklander, Subramanian Suriyanarayanan
Akademy: Torgny Fornstedt (project director) & Jörgen Samuelsson, Karlstad University; Mårten Gulliksson, Örebro University
Industry: A Karlsson & M Klarqvist, AstraZeneca; T Aastrup, Attana; M Palmlöf, AkzoNobel; K Andersson, Ridgeview
Participating organizations
Linnaeus University, Karlstad University, Örebro University, AstraZeneca, AkzoNobel, Attana, Ridgeview
The Synergy program of the Knowledge Foundation (KK-stiftelsen)
Nov 2017-Oct 2020
Chemistry (Department of Chemistry and Biomedical Sciences, Faculty of Technology)

More about the project

New materials and detection techniques are being developed to establish better protocols for the quality assurance of biomolecule-derived pharmaceuticals. This is critical for patient safety.

The project is part of the research in the Bioorganic and Biophysical Chemistry Laboratory (BBCL) research group and thus part of the research at Linnæus University Centre of Excellence (LNUC) for Biomaterials Chemistry.